Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Barrett's esophagus: prevalence and incidence of adenocarcinomas.

Shields HM, Nardone G, Zhao J, Wang W, Xing Z, Fang D, Jacobson BC, Romero Y, Dvorak K, Goldman A, Pellegrini CA, Wiley EL, Peura DA, Tatum RP, Schnell TG.

Ann N Y Acad Sci. 2011 Sep;1232:230-47. doi: 10.1111/j.1749-6632.2011.06054.x.

PMID:
21950816
2.

Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.

Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC.

Aliment Pharmacol Ther. 2008 Feb 15;27(4):321-6. Epub 2007 Nov 28.

3.

Barrett's esophagus and risk of esophageal adenocarcinoma.

Cossentino MJ, Wong RK.

Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Review.

PMID:
14653412
4.

Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer.

Falk GW, Thota PN, Richter JE, Connor JT, Wachsberger DM.

Clin Gastroenterol Hepatol. 2005 Nov;3(11):1089-94.

PMID:
16271339
5.
6.

Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.

Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.

Am J Gastroenterol. 2005 Apr;100(4):775-83.

PMID:
15784018
7.

Surveillance in Barrett's esophagus: an audit of practice.

Ajumobi A, Bahjri K, Jackson C, Griffin R.

Dig Dis Sci. 2010 Jun;55(6):1615-21. doi: 10.1007/s10620-009-0917-y. Epub 2009 Aug 11.

PMID:
19669878
8.

Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE.

Am J Gastroenterol. 1997 Nov;92(11):2012-6.

PMID:
9362182
9.

Screening and surveillance for complications related to gastroesophageal reflux disease.

Spechler SJ.

Am J Med. 2001 Dec 3;111 Suppl 8A:130S-136S. Review.

PMID:
11749938
10.
11.

Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.

Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.

J Gastroenterol Hepatol. 2003 Jun;18(6):683-9.

PMID:
12753151
12.

[Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].

Zaninotto G, Costantini M, Molena D, Rizzetto C, Ekser B, Ancona E.

Minerva Chir. 2002 Dec;57(6):819-36. Review. Italian.

PMID:
12592224
13.

Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.

Dent J.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:11-30. doi: 10.1111/j.1440-1746.2010.06535.x. Review.

PMID:
21199510
14.

Surgical management of high-grade dysplasia in Barrett's esophagus.

Rice TW, Falk GW, Achkar E, Petras RE.

Am J Gastroenterol. 1993 Nov;88(11):1832-6.

PMID:
8237928
15.

Advances in Barrett's esophagus and esophageal adenocarcinoma.

Shaheen NJ.

Gastroenterology. 2005 May;128(6):1554-66. Review.

PMID:
15887151
16.
17.

Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.

Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM.

Gastroenterology. 2002 Jan;122(1):26-33. Review.

PMID:
11781277
18.

Adenocarcinoma in Barrett's esophagus.

Altorki NK, Skinner DB.

Semin Surg Oncol. 1990;6(5):274-8. Review.

PMID:
2237086
19.

Barrett's esophagus and Barrett's carcinoma.

von Rahden BH, Stein HJ, Siewert JR.

Curr Oncol Rep. 2003 May;5(3):203-9. Review.

PMID:
12667417
20.

Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.

Falk GW, Rice TW, Goldblum JR, Richter JE.

Gastrointest Endosc. 1999 Feb;49(2):170-6.

PMID:
9925694
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk